Ligand Pharmaceuticals Incorporated
Ownership
Ownership Structure
Who owns Ligand Pharmaceuticals Incorporated (LGND)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.7% of the shares are freely tradable; institutional investors hold 106.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 14.86 | 2,961,923 | +0.7 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.52 | 1,100,267 | +0.0 | 03/31/2026 |
| HHG PLC | 5.07 | 1,009,891 | +1.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.25 | 848,089 | +0.0 | 03/31/2026 |
| Amvescap Plc. | 4.13 | 823,604 | +59.5 | 03/31/2026 |
| State Street Corp | 3.91 | 778,856 | +3.7 | 03/31/2026 |
| Congress Asset Management Company, LLP | 3.31 | 659,911 | +30.8 | 06/30/2026 |
| FMR Inc | 2.99 | 596,127 | +2.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.13 | 1,221,600 | +0.0 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.05 | 607,994 | +0.4 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Reardon Andrew | CLO & Secretary | 36,514 | 10,395,536 $ | Sep 3, 2026 | direct |
| Espinoza Octavio | Chief Financial Officer | 27,696 | 7,885,051 $ | Aug 12, 2026 | direct |
| Haas Jason | Director | 3,981 | 1,133,391 $ | Aug 12, 2026 | direct |
| Zimmermann Martine | Director | 3,897 | 1,109,476 $ | Sep 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Zimmermann Martine | Director | Sell | 1,200 | 285.00 | 342,000 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 400 | 288.98 | 115,592 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 385 | 287.53 | 110,697 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 2,115 | 286.36 | 605,649 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,800 | 285.17 | 513,301 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 300 | 283.99 | 85,196 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Sell | 31,641 | 292.07 | 9,241,229 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 3,348 | 68.74 | 230,142 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 7,171 | 57.22 | 410,325 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 2,869 | 55.75 | 159,947 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 2,074 | 70.04 | 145,263 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 16,179 | 52.84 | 854,898 |
| Aug 12, 2026 | Haas Jason | Director | Sell | 7,138 | 292.81 | 2,090,062 |
| Aug 12, 2026 | Haas Jason | Director | Other | 6,138 | 51.56 | 316,475 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 409 | 292.82 | 119,763 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 991 | 291.71 | 289,086 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 200 | 290.60 | 58,120 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 503 | 289.80 | 145,771 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 356 | 288.75 | 102,795 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,214 | 287.77 | 349,357 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,032 | 286.80 | 295,974 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 157 | 285.74 | 44,861 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 33 | 284.55 | 9,390 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 105 | 284.14 | 29,834 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Other | 5,000 | 52.27 | 261,350 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.